Oxidized phospholipids in control of inflammation and endothelial barrier.

Oxidized phospholipids in control of inflammation and endothelial barrier.
复制标题

DOI:
10.1016/j.trsl.2008.12.005
复制
发表时间:
2009-04
期刊:
Translational research : the journal of laboratory and clinical medicine
影响因子:
--
通讯作者:
Birukov KG
Birukov KG
中科院分区:
其他
文献类型:
--
作者:
Fu P;Birukov KG

文献摘要

参考文献

被引文献

相似文献

在高脂血症、动脉粥样硬化、系统性红斑狼疮、血管球囊损伤、急性肺损伤(ALI)和急性呼吸窘迫综合征(ARDS)等慢性和急性病理条件下,循环氧化磷脂(Oxpls)水平升高。这些病理与内皮细胞的炎症和激活有关。根据生物背景和特定的磷脂氧化产物组,OxPL可能既有促炎作用,也有抗炎作用。本文综述了OxPL在调节慢性和急性炎症中的双重作用以及OxPL对肺内皮细胞通透性的影响。最近的报道显示了OxPL在内毒素和呼吸机诱导的ALI模型中的保护作用,并暗示了将OxPL衍生的具有屏障保护特性的环烯酮化合物用于药物设计的可能性。这些化合物可能代表了一组新的治疗药物,用于治疗与急性炎症和肺血管渗漏相关的肺综合征。
The levels of circulating oxidized phospholipids (OxPLs) become increased in chronic and acute pathologic conditions such as hyperlipidemia, atherosclerosis, increased intimamedia thickness in the patients with systemic Lupus erythematosus, vascular balloon injury, acute lung injury (ALI), and acute respiratory distress syndrome (ARDS). These pathologies are associated with inflammation and activation of endothelial cells. Depending on the biological context and the specific group of phospholipid oxidation products, OxPL may exhibit both proinflammatory and anti-inflammatory effects. This review will summarize the data showing a dual role of OxPL in modulation of chronic and acute inflammation as well as OxPL effects on pulmonary endothelial permeability. Recent reports show protective effects of OxPL in the models of endotoxin and ventilator-induced ALI and suggest a potential for using OxPL-derived cyclopenthenone-containing compounds with barrier-protective properties for drug design. These compounds may represent a new group of therapeutic agents for the treatment of lung syndromes associated with acute inflammation and lung vascular leak.
DOI: 10.1074/jbc.m704267200
发表时间: 2007-10-26
影响因子: 4.8
作者:
Gharavi, Nima M.;Alva, Jackelyn A.;Berliner, Judith A.
通讯作者: Berliner, Judith A.
DOI: 10.1084/jem.20031763
发表时间: 2004-12-06
期刊: The Journal of experimental medicine
影响因子: --
作者:
Chang MK;Binder CJ;Miller YI;Subbanagounder G;Silverman GJ;Berliner JA;Witztum JL
通讯作者: Witztum JL
DOI: 10.1074/jbc.m313349200
发表时间: 2004-04-02
影响因子: 4.8
作者:
Brame, CJ;Boutaud, O;Roberts, LJ
通讯作者: Roberts, LJ
DOI: 10.1152/ajplung.00395.2006
发表时间: 2007-04-01
影响因子: 4.9
作者:
Birukova, Anna A.;Fu, Panfeng;Birukov, Konstantin G.
通讯作者: Birukov, Konstantin G.
DOI: 10.1016/j.mvr.2006.12.004
发表时间: 2007-05-01
影响因子: 3.1
作者:
Birukova, Anna A.;Chatchavalvanich, Santipongse;Birukov, Konstantin G.
通讯作者: Birukov, Konstantin G.